Seramic Pharmaceuticals Private Limited
About Seramic Pharmaceuticals Private Limited
Data last updated:
Seramic Pharmaceuticals Private Limited is a private limited company based in Bhiwandi, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 June 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2022PTC384354. Its GSTIN is 27ABICS7015B1ZJ (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Nitin Prakash Lodha and Ishan Nitin Lodha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhiwandi, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹67.42 Lakh, a decline of 49% compared to the previous year. For the same year it recorded a net profit of ₹41,348 (net margin 0.6%) and EBITDA of ₹63,554 (EBITDA margin 0.9%).
Company details
Contact details
Seramic Pharmaceuticals Private Limited's registered office is in Bhiwandi, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBuilding No E – 6 B Wing Unit No.10 Ground Floor, Asmeeta Texpa II Kongaon, Bhiwandi, Maharashtra, India – 421311
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Seramic Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Seramic Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Seramic Pharmaceuticals Private Limited, buy the company report.
Financials of Seramic Pharmaceuticals Private Limited
FY 2025 filings availableSeramic Pharmaceuticals Private Limited reported revenue of ₹67.42 Lakh (down 49% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 49% in the latest year. EBITDA fell 45% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹63,554 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹41,348 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.9% | ||
| Net Profit Margin | 0.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Seramic Pharmaceuticals Private Limited, buy the company report.
Board of directors of Seramic Pharmaceuticals Private Limited
Seramic Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Prakash Lodha | Director | 30 Jun 2025 | 1 Years 3 Months | Current |
| Ishan Nitin Lodha Also directs: Hridhun Pharma Private Limited | Director | 20 Dec 2024 | 1 Years 10 Months | Current |
Peer comparison
Seramic Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Amox Pharmaceuticals Private Limited | ₹67.7 Lakh (FY 2024) | 67.0% | Patna, Bihar, India | |||
| Waxemon Pharmaceuticals (OPC) Private Limited | ₹67.52 Lakh (FY 2025) | 2.0% | Lucknow, Uttar Pradesh, India | |||
| Seramic Pharmaceuticals Private Limitedthis company | ₹67.42 Lakh (FY 2025) | ₹41,348 | 0.6% | -49.0% | Bhiwandi, Maharashtra, India | |
| Amrut Manthan Tradelink Private Limited | ₹67.19 Lakh (FY 2024) | -20.0% | Rajkot, Gujarat, India | |||
| Kalash Metals Private Limited | ₹67.17 Lakh (FY 2025) | -9.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Seramic Pharmaceuticals Private Limited, buy the company report.
Auditor
Seramic Pharmaceuticals Private Limited is audited by B R JAIN & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B R JAIN & CO | FY 2023 | 159299W |
Shareholding
The shareholding of Seramic Pharmaceuticals Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Seramic Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Seramic Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Seramic Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Seramic Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
Seramic Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABICS7015B1ZJ | Maharashtra | Active | 12 Jul 2022 |
To see the full GST registrations and return filing status of Seramic Pharmaceuticals Private Limited, buy the company report.
Recent activity
Seramic Pharmaceuticals Private Limited has 6 board changes on record since 2024: 2 appointments and 4 cessations. The latest: Chirag Deepak Shah ceased to be Director on 01 Jul 2025.
Frequently asked questions
Seramic Pharmaceuticals is an active private limited company based in Bhiwandi, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 June 2022 (4+ years old) and is registered under CIN U24100MH2022PTC384354.
Seramic Pharmaceuticals has 2 current directors:
- Nitin Prakash Lodha - Director
- Ishan Nitin Lodha - Director
The latest financial statements of Seramic Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Seramic Pharmaceuticals is 27ABICS7015B1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Seramic Pharmaceuticals is U24100MH2022PTC384354. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Seramic Pharmaceuticals was incorporated on 10 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Seramic Pharmaceuticals by revenue are Amox Pharmaceuticals Private Limited, Waxemon Pharmaceuticals (OPC) Private Limited, Amrut Manthan Tradelink Private Limited, Kalash Metals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Chirag Deepak Shah ceased to be Director on 01 Jul 2025. Karankumar Bhupatraj Chopra ceased to be Director on 01 Jul 2025. Nitin Prakash Lodha was appointed as Director on 30 Jun 2025. Seramic Pharmaceuticals has 6 board changes on record in total.
The registered office of Seramic Pharmaceuticals is at Building No E – 6 B Wing Unit No.10 Ground Floor, Asmeeta Texpa II Kongaon, Bhiwandi, Maharashtra, India – 421311.
Seramic Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Seramic Pharmaceuticals can be reached at its registered office: Building No E – 6 B Wing Unit No.10 Ground Floor, Asmeeta Texpa II Kongaon, Bhiwandi, Maharashtra, India – 421311.